David P. Lane - Publications

Affiliations: 
Institute of Molecular and Cell Biology (A-STAR), Singapore, Singapore 

86 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Spiegelberg D, Mortensen ACL, Palupi KD, Micke P, Wong J, Vojtesek B, Lane DP, Nestor M. The Novel Anti-cMet Antibody seeMet 12 Potentiates Sorafenib Therapy and Radiotherapy in a Colorectal Cancer Model. Frontiers in Oncology. 10: 1717. PMID 33014851 DOI: 10.3389/fonc.2020.01717  0.52
2019 Turnquist C, Beck JA, Horikawa I, Obiorah IE, von Muhlinen N, Vojtesek B, Lane DP, Grunseich C, Chahine JJ, Ames HM, Smart D, Harris BT, Harris CC. Radiation-induced astrocyte senescence is rescued by Δ133p53. Neuro-Oncology. PMID 30615147 DOI: 10.1093/neuonc/noz001  0.52
2018 Ladds MJGW, van Leeuwen IMM, Drummond CJ, Chu S, Healy AR, Popova G, Pastor Fernández A, Mollick T, Darekar S, Sedimbi SK, Nekulova M, Sachweh MCC, Campbell J, Higgins M, Tuck C, ... ... Lane DP, et al. A DHODH inhibitor increases p53 synthesis and enhances tumor cell killing by p53 degradation blockage. Nature Communications. 9: 1107. PMID 29549331 DOI: 10.1038/s41467-018-03441-3  0.52
2018 von Muhlinen N, Horikawa I, Alam F, Isogaya K, Lissa D, Vojtesek B, Lane DP, Harris CC. p53 isoforms regulate premature aging in human cells. Oncogene. PMID 29429991 DOI: 10.1038/s41388-017-0101-3  0.52
2017 Muller P, Chan JM, Simoncik O, Fojta M, Lane DP, Hupp T, Vojtesek B. Evidence for allosteric effects on p53 oligomerization induced by phosphorylation. Protein Science : a Publication of the Protein Society. PMID 29124793 DOI: 10.1002/pro.3344  0.64
2016 Siau JW, Coffill CR, Zhang WV, Tan YS, Hundt J, Lane D, Verma C, Ghadessy F. Functional characterization of p53 pathway components in the ancient metazoan Trichoplax adhaerens. Scientific Reports. 6: 33972. PMID 27678309 DOI: 10.1038/srep33972  0.32
2016 Tan YS, Reeks J, Brown CJ, Thean D, Ferrer Gago FJ, Yuen TY, Goh ET, Lee XE, Jennings CE, Joseph TL, Lakshminarayanan R, Lane DP, Noble ME, Verma CS. Benzene Probes in Molecular Dynamics Simulations Reveal Novel Binding Sites for Ligand Design. The Journal of Physical Chemistry Letters. PMID 27532490 DOI: 10.1021/acs.jpclett.6b01525  0.32
2016 Tan YS, Lane DP, Verma CS. Stapled peptide design: principles and roles of computation. Drug Discovery Today. PMID 27326912 DOI: 10.1016/j.drudis.2016.06.012  0.32
2016 Turnquist C, Horikawa I, Foran E, Major EO, Vojtesek B, Lane DP, Lu X, Harris BT, Harris CC. p53 isoforms regulate astrocyte-mediated neuroprotection and neurodegeneration. Cell Death and Differentiation. PMID 27104929 DOI: 10.1038/cdd.2016.37  0.32
2016 Kannan S, Lane DP, Verma CS. Long range recognition and selection in IDPs: the interactions of the C-terminus of p53. Scientific Reports. 6: 23750. PMID 27030593 DOI: 10.1038/srep23750  0.32
2016 Coffill CR, Lee AP, Siau JW, Chee SM, Joseph TL, Tan YS, Madhumalar A, Tay BH, Brenner S, Verma CS, Ghadessy FJ, Venkatesh B, Lane DP. The p53-Mdm2 interaction and the E3 ligase activity of Mdm2/Mdm4 are conserved from lampreys to humans. Genes & Development. PMID 26798135 DOI: 10.1101/gad.274118.115  0.32
2015 Eng HY, Wang CI, Xue Y, Lee CY, Binte Zulkifli S, Chiam PC, Ghadessy FJ, Lane DP. Enhanced antigen detection in immunohistochemical staining using a 'digitized' chimeric antibody. Protein Engineering, Design & Selection : Peds. PMID 26508747 DOI: 10.1093/protein/gzv054  0.32
2015 Lama D, Brown CJ, Lane DP, Verma CS. Gating by Tryptophan 73 Exposes a Cryptic Pocket at the Protein-Binding Interface of the Oncogenic eIF4E Protein. Biochemistry. PMID 26427906 DOI: 10.1021/acs.biochem.5b00812  0.32
2015 Goh AM, Xue Y, Leushacke M, Li L, Wong JS, Chiam PC, Rahmat SA, Mann MB, Mann KM, Barker N, Lozano G, Terzian T, Lane DP. Mutant p53 accumulates in cycling and proliferating cells in the normal tissues of p53 R172H mutant mice. Oncotarget. 6: 17968-80. PMID 26255629  0.32
2015 Tan BX, Brown CJ, Ferrer FJ, Yuen TY, Quah ST, Chan BH, Jansson AE, Teo HL, Nordlund P, Lane DP. Assessing the Efficacy of Mdm2/Mdm4-Inhibiting Stapled Peptides Using Cellular Thermal Shift Assays. Scientific Reports. 5: 12116. PMID 26159518 DOI: 10.1038/srep12116  0.32
2015 ElSawy KM, Sim A, Lane DP, Verma CS, Caves LS. A spatiotemporal characterization of the effect of p53 phosphorylation on its interaction with MDM2. Cell Cycle (Georgetown, Tex.). 14: 179-88. PMID 25584963 DOI: 10.4161/15384101.2014.989043  0.32
2014 Horikawa I, Fujita K, Jenkins LM, Hiyoshi Y, Mondal AM, Vojtesek B, Lane DP, Appella E, Harris CC. Autophagic degradation of the inhibitory p53 isoform Δ133p53α as a regulatory mechanism for p53-mediated senescence. Nature Communications. 5: 4706. PMID 25144556 DOI: 10.1038/ncomms5706  0.52
2014 Huang YF, Wee S, Gunaratne J, Lane DP, Bulavin DV. Isg15 controls p53 stability and functions. Cell Cycle (Georgetown, Tex.). 13: 2200-10. PMID 24844324 DOI: 10.4161/cc.29209  0.32
2014 Sim AYL, Joseph T, Lane DP, Verma C. Mechanism of stapled peptide binding to MDM2: Possible consequences for peptide design Journal of Chemical Theory and Computation. 10: 1753-1761. DOI: 10.1021/ct4009238  0.32
2013 Mondal AM, Horikawa I, Pine SR, Fujita K, Morgan KM, Vera E, Mazur SJ, Appella E, Vojtesek B, Blasco MA, Lane DP, Harris CC. p53 isoforms regulate aging- and tumor-associated replicative senescence in T lymphocytes. The Journal of Clinical Investigation. 123: 5247-57. PMID 24231352 DOI: 10.1172/JCI70355  0.52
2013 Wong JS, Warbrick E, Vojtesk B, Hill J, Lane DP. Anti-c-Met antibodies recognising a temperature sensitive epitope, inhibit cell growth. Oncotarget. 4: 1019-36. PMID 23859937  0.32
2013 ElSawy KM, Verma CS, Joseph TL, Lane DP, Twarock R, Caves LS. On the interaction mechanisms of a p53 peptide and nutlin with the MDM2 and MDMX proteins: a Brownian dynamics study. Cell Cycle (Georgetown, Tex.). 12: 394-404. PMID 23324352 DOI: 10.4161/cc.23511  0.32
2013 Brown CJ, Quah ST, Jong J, Goh AM, Chiam PC, Khoo KH, Choong ML, Lee MA, Yurlova L, Zolghadr K, Joseph TL, Verma CS, Lane DP. Stapled peptides with improved potency and specificity that activate p53. Acs Chemical Biology. 8: 506-12. PMID 23214419 DOI: 10.1021/cb3005148  0.32
2013 Guo L, Liew HP, Camus S, Goh AM, Chee LL, Lunny DP, Lane EB, Lane DP. Ionizing radiation induces a dramatic persistence of p53 protein accumulation and DNA damage signaling in mutant p53 zebrafish. Oncogene. 32: 4009-16. PMID 23069659 DOI: 10.1038/onc.2012.409  0.32
2013 Muller P, Ruckova E, Halada P, Coates PJ, Hrstka R, Lane DP, Vojtesek B. C-terminal phosphorylation of Hsp70 and Hsp90 regulates alternate binding to co-chaperones CHIP and HOP to determine cellular protein folding/degradation balances. Oncogene. 32: 3101-10. PMID 22824801 DOI: 10.1038/onc.2012.314  0.52
2012 Goh AM, Lane DP. How p53 wields the scales of fate: arrest or death? Transcription. 3: 240-4. PMID 22885979 DOI: 10.4161/trns.21297  0.32
2011 Dastidar SG, Raghunathan D, Nicholson J, Hupp TR, Lane DP, Verma CS. Chemical states of the N-terminal "lid" of MDM2 regulate p53 binding: simulations reveal complexities of modulation. Cell Cycle (Georgetown, Tex.). 10: 82-9. PMID 21191186 DOI: 10.4161/cc.10.1.14345  0.88
2010 Fujita K, Horikawa I, Mondal AM, Jenkins LM, Appella E, Vojtesek B, Bourdon JC, Lane DP, Harris CC. Positive feedback between p53 and TRF2 during telomere-damage signalling and cellular senescence. Nature Cell Biology. 12: 1205-12. PMID 21057505 DOI: 10.1038/ncb2123  0.52
2010 Wang S, Griffiths G, Midgley CA, Barnett AL, Cooper M, Grabarek J, Ingram L, Jackson W, Kontopidis G, McClue SJ, McInnes C, McLachlan J, Meades C, Mezna M, Stuart I, ... ... Lane DP, et al. Discovery and characterization of 2-anilino-4- (thiazol-5-yl)pyrimidine transcriptional CDK inhibitors as anticancer agents. Chemistry & Biology. 17: 1111-21. PMID 21035734 DOI: 10.1016/j.chembiol.2010.07.016  0.32
2010 Goh AM, Lane DP. SNPing Away at Cancer. Cancer Cell. 18: 201-2. PMID 20832747 DOI: 10.1016/j.ccr.2010.08.016  0.32
2010 Wang S, Midgley CA, Scaërou F, Grabarek JB, Griffiths G, Jackson W, Kontopidis G, McClue SJ, McInnes C, Meades C, Mezna M, Plater A, Stuart I, Thomas MP, Wood G, ... ... Lane DP, et al. Discovery of N-phenyl-4-(thiazol-5-yl)pyrimidin-2-amine aurora kinase inhibitors. Journal of Medicinal Chemistry. 53: 4367-78. PMID 20462263 DOI: 10.1021/jm901913s  0.32
2009 Bourdon J, Diot A, Vojtesek B, Bray S, Jordan L, Lane DP, Thompson A. Scotin expression and survival in breast cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: e22006. PMID 27963176 DOI: 10.1200/jco.2009.27.15_suppl.e22006  0.52
2009 Brown CJ, Lain S, Verma CS, Fersht AR, Lane DP. Awakening guardian angels: drugging the p53 pathway. Nature Reviews. Cancer. 9: 862-73. PMID 19935675 DOI: 10.1038/nrc2763  0.32
2009 Fujita K, Mondal AM, Horikawa I, Nguyen GH, Kumamoto K, Sohn JJ, Bowman ED, Mathe EA, Schetter AJ, Pine SR, Ji H, Vojtesek B, Bourdon JC, Lane DP, Harris CC. p53 isoforms Delta133p53 and p53beta are endogenous regulators of replicative cellular senescence. Nature Cell Biology. 11: 1135-42. PMID 19701195 DOI: 10.1038/ncb1928  0.32
2009 Appleyard MV, O'Neill MA, Murray KE, Paulin FE, Bray SE, Kernohan NM, Levison DA, Lane DP, Thompson AM. Seliciclib (CYC202, R-roscovitine) enhances the antitumor effect of doxorubicin in vivo in a breast cancer xenograft model. International Journal of Cancer. Journal International Du Cancer. 124: 465-72. PMID 19003963 DOI: 10.1002/ijc.23938  0.32
2008 Staples OD, Hollick JJ, Campbell J, Higgins M, McCarthy AR, Appleyard V, Murray KE, Baker L, Thompson A, Ronseaux S, Slawin AM, Lane DP, Westwood NJ, Lain S. Characterization, chemical optimization and anti-tumour activity of a tubulin poison identified by a p53-based phenotypic screen. Cell Cycle (Georgetown, Tex.). 7: 3417-27. PMID 18971638  0.32
2008 Avery-Kiejda KA, Zhang XD, Adams LJ, Scott RJ, Vojtesek B, Lane DP, Hersey P. Small molecular weight variants of p53 are expressed in human melanoma cells and are induced by the DNA-damaging agent cisplatin. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 14: 1659-68. PMID 18310316 DOI: 10.1158/1078-0432.CCR-07-1422  0.52
2008 Muller P, Hrstka R, Coomber D, Lane DP, Vojtesek B. Chaperone-dependent stabilization and degradation of p53 mutants. Oncogene. 27: 3371-83. PMID 18223694 DOI: 10.1038/sj.onc.1211010  0.52
2008 Lee KC, Goh WL, Xu M, Kua N, Lunny D, Wong JS, Coomber D, Vojtesek B, Lane EB, Lane DP. Detection of the p53 response in zebrafish embryos using new monoclonal antibodies. Oncogene. 27: 629-40. PMID 17684488 DOI: 10.1038/sj.onc.1210695  0.52
2005 MacCallum DE, Melville J, Frame S, Watt K, Anderson S, Gianella-Borradori A, Lane DP, Green SR. Seliciclib (CYC202, R-Roscovitine) induces cell death in multiple myeloma cells by inhibition of RNA polymerase II-dependent transcription and down-regulation of Mcl-1. Cancer Research. 65: 5399-407. PMID 15958589 DOI: 10.1158/0008-5472.CAN-05-0233  0.32
2005 Bates GJ, Nicol SM, Wilson BJ, Jacobs AMF, Bourdon JC, Wardrop J, Gregory DJ, Lane DP, Perkins ND, Fuller-Pace FV. The DEAD box protein p68: A novel transcriptional coactivator of the p53 tumour suppressor Embo Journal. 24: 543-553. PMID 15660129 DOI: 10.1038/sj.emboj.7600550  0.32
2003 Lane DP, Hupp TR. Drug discovery and p53. Drug Discovery Today. 8: 347-55. PMID 12681938  0.88
2003 Camus S, Higgins M, Lane DP, Lain S. Differences in the ubiquitination of p53 by Mdm2 and the HPV protein E6. Febs Letters. 536: 220-4. PMID 12586367 DOI: 10.1016/S0014-5793(03)00054-1  0.32
2002 McClue SJ, Blake D, Clarke R, Cowan A, Cummings L, Fischer PM, MacKenzie M, Melville J, Stewart K, Wang S, Zhelev N, Zheleva D, Lane DP. In vitro and in vivo antitumor properties of the cyclin dependent kinase inhibitor CYC202 (R-roscovitine). International Journal of Cancer. Journal International Du Cancer. 102: 463-8. PMID 12432547 DOI: 10.1002/ijc.10738  0.32
2002 Shreeram S, Sparks A, Lane DP, Blow JJ. Cell type-specific responses of human cells to inhibition of replication licensing. Oncogene. 21: 6624-32. PMID 12242660 DOI: 10.1038/sj.onc.1205910  0.32
2000 Rodriguez MS, Desterro JM, Lain S, Lane DP, Hay RT. Multiple C-terminal lysine residues target p53 for ubiquitin-proteasome-mediated degradation. Molecular and Cellular Biology. 20: 8458-67. PMID 11046142 DOI: 10.1128/MCB.20.22.8458-8467.2000  0.32
2000 Hietanen S, Lain S, Krausz E, Blattner C, Lane DP. Activation of p53 in cervical carcinoma cells by small molecules. Proceedings of the National Academy of Sciences of the United States of America. 97: 8501-6. PMID 10900010 DOI: 10.1073/pnas.97.15.8501  0.32
2000 Zheleva DI, Zhelev NZ, Fischer PM, Duff SV, Warbrick E, Blake DG, Lane DP. A quantitative study of the in vitro binding of the C-terminal domain of p21 to PCNA: affinity, stoichiometry, and thermodynamics. Biochemistry. 39: 7388-97. PMID 10858286 DOI: 10.1021/bi992498r  0.32
2000 Burch LR, Midgley CA, Currie RA, Lane DP, Hupp TR. Mdm2 binding to a conformationally sensitive domain on p53 can be modulated by RNA. Febs Letters. 472: 93-8. PMID 10781812 DOI: 10.1016/S0014-5793(00)01427-7  0.4
2000 HUPP TR, LANE DP, BALL KL. Strategies for manipulating the p53 pathway in the treatment of human cancer Biochemical Journal. 352: 1-17. DOI: 10.1042/BJ3520001  0.32
1999 Cohen PA, Hupp TR, Lane DP, Daniels DA. Biochemical characterization of different conformational states of the Sf9 cell-purified p53His175 mutant protein. Febs Letters. 463: 179-84. PMID 10601663 DOI: 10.1016/S0014-5793(99)01603-8  0.88
1999 Kendall MD, Lane DP, Schumacher U. Immunohistochemical and ultrastructural evidence for myelopoiesis in the scid/scid mouse thymus Histochemical Journal. 31: 651-660. PMID 10576414 DOI: 10.1023/A:1003895519669  0.32
1999 Rodriguez MS, Desterro JM, Lain S, Midgley CA, Lane DP, Hay RT. SUMO-1 modification activates the transcriptional response of p53. The Embo Journal. 18: 6455-61. PMID 10562557 DOI: 10.1093/emboj/18.22.6455  0.32
1999 Laín S, Midgley C, Sparks A, Lane EB, Lane DP. An inhibitor of nuclear export activates the p53 response and induces the localization of HDM2 and p53 to U1A-positive nuclear bodies associated with the PODs. Experimental Cell Research. 248: 457-72. PMID 10222137 DOI: 10.1006/excr.1999.4433  0.32
1998 Lindner K, Mole SE, Lane DP, Kenny MK. Epitope mapping of antibodies recognising the N-terminal domain of simian virus large tumour antigen. Intervirology. 41: 10-6. PMID 9705560 DOI: 10.1159/000024910  0.32
1997 Fourie AM, Hupp TR, Lane DP, Sang BC, Barbosa MS, Sambrook JF, Gething MJ. HSP70 binding sites in the tumor suppressor protein p53. The Journal of Biological Chemistry. 272: 19471-9. PMID 9235949 DOI: 10.1074/jbc.272.31.19471  0.32
1997 Midgley CA, White S, Howitt R, Save V, Dunlop MG, Hall PA, Lane DP, Wyllie AH, Bubb VJ. APC expression in normal human tissues. The Journal of Pathology. 181: 426-33. PMID 9196441 DOI: 10.1002/(SICI)1096-9896(199704)181:4<426::AID-PATH768>3.0.CO;2-T  0.32
1996 Hansen S, Midgley CA, Lane DP, Freeman BC, Morimoto RI, Hupp TR. Modification of two distinct COOH-terminal domains is required for murine p53 activation by bacterial Hsp70. The Journal of Biological Chemistry. 271: 30922-8. PMID 8940078 DOI: 10.1074/jbc.271.48.30922  0.32
1996 Fåhraeus R, Paramio JM, Ball KL, Laín S, Lane DP. Inhibition of pRb phosphorylation and cell-cycle progression by a 20-residue peptide derived from p16CDKN2/INK4A. Current Biology : Cb. 6: 84-91. PMID 8805225 DOI: 10.1016/S0960-9822(02)00425-6  0.32
1996 Frosina G, Fortini P, Rossi O, Carrozzino F, Raspaglio G, Cox LS, Lane DP, Abbondandolo A, Dogliotti E. Two pathways for base excision repair in mammalian cells Journal of Biological Chemistry. 271: 9573-9578. PMID 8621631 DOI: 10.1074/jbc.271.16.9573  0.32
1996 Kernohan NM, Hupp TR, Lane DP. Modification of an N-terminal regulatory domain of T antigen restores p53-T antigen complex formation in the absence of an essential metal ion cofactor. The Journal of Biological Chemistry. 271: 4954-60. PMID 8617769 DOI: 10.1074/JBC.271.9.4954  0.56
1995 Hupp TR, Lane DP. Allosteric activation of latent p53 tetramers. Current Biology : Cb. 4: 865-75. PMID 7850419 DOI: 10.1016/S0960-9822(00)00195-0  0.88
1995 Warbrick E, Lane DP, Glover DM, Cox LS. A small peptide inhibitor of DNA replication defines the site of interaction between the cyclin-dependent kinase inhibitor p21WAF1 and proliferating cell nuclear antigen Current Biology. 5: 275-282. PMID 7780738 DOI: 10.1016/S0960-9822(95)00058-3  0.32
1995 Vojtesek B, Kovarik J, Dolezalova H, Nenutil R, Havlis P, Brentani RR, Lane DP. Absence of p53 autoantibodies in a significant proportion of breast cancer patients. British Journal of Cancer. 71: 1253-6. PMID 7779720  0.52
1995 Hupp TR, Lane DP. Two distinct signaling pathways activate the latent DNA binding function of p53 in a casein kinase II-independent manner. The Journal of Biological Chemistry. 270: 18165-74. PMID 7629129 DOI: 10.1074/JBC.270.30.18165  0.68
1995 Hupp TR, Lane DP. Regulation of the cryptic sequence-specific DNA-binding function of p53 by protein kinases. Cold Spring Harbor Symposia On Quantitative Biology. 59: 195-206. PMID 7587070 DOI: 10.1101/SQB.1994.059.01.024  0.44
1995 Hupp TR, Sparks A, Lane DP. Small peptides activate the latent sequence-specific DNA binding function of p53 Cell. 83: 237-245. PMID 7585941 DOI: 10.1016/0092-8674(95)90165-5  0.32
1995 Cox LS, Lane DP. Tumour suppressors, kinases and clamps: How p53 regulates the cell cycle in response to DNA damage Bioessays. 17: 501-508. PMID 7575491 DOI: 10.1002/bies.950170606  0.32
1994 Picksley SM, Hupp TR, Lu X, Midgley CA, Vojtesek B, Lane DP. Regulation of p53 protein expression in human cancer Cancer Genetics and Cytogenetics. 77: 153. DOI: 10.1016/0165-4608(94)90250-X  0.88
1993 Lane DP, Midgley C, Hupp T. Tumour suppressor genes and molecular chaperones. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences. 339: 369-72; discussion 3. PMID 8493291 DOI: 10.1098/rstb.1993.0036  0.64
1993 Hupp TR, Meek DW, Midgley CA, Lane DP. Activation of the cryptic DNA binding function of mutant forms of p53. Nucleic Acids Research. 21: 3167-74. PMID 8341590 DOI: 10.1093/NAR/21.14.3167  0.32
1993 Joypaul BV, Vojtesek B, Newman EL, Hopwood D, Grant A, Lane DP, Cuschieri A. Enzyme-linked immunosorbent assay for p53 in gastrointestinal malignancy: comparison with immunohistochemistry. Histopathology. 23: 465-70. PMID 8314221 DOI: 10.1111/j.1365-2559.1993.tb00496.x  0.52
1993 Lu X, Lane DP. Differential induction of transcriptionally active p53 following UV or ionizing radiation: defects in chromosome instability syndromes? Cell. 75: 765-78. PMID 8242748 DOI: 10.1016/0092-8674(93)90496-D  0.32
1993 Filipe MI, Mendes R, Lane DP, Morris RW. Assessment of proliferating cell nuclear antigen expression in precursor stages of gastric carcinoma using the PC10 antibody in PCNA Histopathology. 22: 349-354. PMID 8099897 DOI: 10.1111/j.1365-2559.1993.tb00134.x  0.32
1992 Lu X, Park SH, Thompson TC, Lane DP. Ras-induced hyperplasia occurs with mutation of p53, but activated ras and myc together can induce carcinoma without p53 mutation. Cell. 70: 153-61. PMID 1623518 DOI: 10.1016/0092-8674(92)90541-J  0.32
1992 Hupp TR, Meek DW, Midgley CA, Lane DP. Regulation of the specific DNA binding function of p53. Cell. 71: 875-86. PMID 1423635 DOI: 10.1016/0092-8674(92)90562-Q  0.88
1992 Vahakangas KH, Metcalf RA, Welsh JA, Bennett WP, Harris CC, Samet JM, Lane DP. Mutations of p53 and ras genes in radon-associated lung cancer from uranium miners The Lancet. 339: 576-580. PMID 1347094 DOI: 10.1016/0140-6736(92)90866-2  0.32
1991 Yu CCW, Hall PA, Fletcher CDM, Camplejohn RS, Waseem NH, Lane DP, Levison DA. Haemangiopericytomas: The prognostic value of immunohistochemical staining with a monoclonal antibody to proliferating cell nuclear antigen (PCNA) Histopathology. 19: 29-33. PMID 1680785 DOI: 10.1111/j.1365-2559.1991.tb00891.x  0.32
1991 Woods AL, Hall PA, Shepherd NA, Hanby AM, Waseem NH, Lane DP, Levison DA. The assessment of proliferating cell nuclear antigen (PCNA) immunostaining in primary gastrointestinal lymphomas and its relationship to histological grade, S + G2 + M phase fraction (flow cytometric analysis) and prognosis Histopathology. 19: 21-27. PMID 1680784 DOI: 10.1111/j.1365-2559.1991.tb00890.x  0.32
1991 Jain S, Filipe MI, Hall PA, Waseem N, Lane DP, Levison DA. Prognostic value of proliferating cell nuclear antigen in gastric carcinoma Journal of Clinical Pathology. 44: 655-659. PMID 1679766 DOI: 10.1136/jcp.44.8.655  0.32
1986 Yewdell JW, Gannon JV, Lane DP. Monoclonal antibody analysis of p53 expression in normal and transformed cells. Journal of Virology. 59: 444-52. PMID 2426467 DOI: 10.1128/JVI.59.2.444-452.1986  0.36
1985 Gorman CM, Lane DP, Watson CJ, Rigby PW. The regulation of gene expression in murine teratocarcinoma cells Cold Spring Harbor Symposia On Quantitative Biology. 50: 701-706. PMID 3007011 DOI: 10.1101/SQB.1985.050.01.086  0.32
1985 Gorman CM, Rigby PWJ, Lane DP. Negative regulation of viral enhancers in undifferentiated embryonic stem cells Cell. 42: 519-526. PMID 2992802 DOI: 10.1016/0092-8674(85)90109-6  0.32
1984 Gorman CM, Lane DP, Rigby PW. High efficiency gene transfer into mammalian cells Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences. 307: 343-346. PMID 6151707 DOI: 10.1098/RSTB.1984.0137  0.32
1981 Lane DP, Lane EB. A rapid antibody assay system for screening hybridoma cultures Journal of Immunological Methods. 47: 303-307. PMID 7037967 DOI: 10.1016/0022-1759(81)90286-6  0.32
1980 Crawford LV, Lane DP, Denhardt DT, Harlow EE, Nicklin PM, Osborn K, Pim DC. Characterization of the complex between SV40 large T antigen and the 53K host protein in transformed mouse cells. Cold Spring Harbor Symposia On Quantitative Biology. 44: 179-87. PMID 6253132 DOI: 10.1101/SQB.1980.044.01.021  0.32
Show low-probability matches.